MarkLTykocinskiMD

Anatomic Pathology

Professor, Pathology, Anatomy and Cell Biology, Jefferson Medical College-Thos Jefferson Univ

Dr. Tykocinski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Spruce St
Philadelphia, PA 19104
Phone+1 215-662-6880

Fax+1 215-349-5864

PubMed

45 citations
CTLA-4·Ig converts naive CD4+CD25− T cells into CD4+CD25+ regulatory T cells
Marjaneh Razmara, Brendan Hilliard, Azadeh K. Ziarani, Youhai H. Chen, Mark L. Tykocinski
International Immunology. 2008-04-01
624 citations
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Yukiko Tone, Keiji Furuuchi, Yoshitsugu Kojima, Mark L. Tykocinski, Mark I. Greene
Nature Immunology. 2008-02-01
127 citations
Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation.
D. Branch Moody, Volker Briken, Tan Yun Cheng, Carme Roura-Mir, Mark R. Guy
Nature Immunology. 2002-04-08

Jefferson Names Joseph G. Cacchione, MD New CEO of Jefferson Health and Thomas Jefferson UniversityAugust 1st, 2022
Jefferson Health Makes Strides in Treating Loss of Smell and TasteMarch 2nd, 2022
Stephen K. Klasko Announces Retirement PlansOctober 14th, 2021
Join now to see all

Cellular Cancer VaccinesNational Cancer Institute2003–2007
Engineering Artifical Veto CellsNational Institute Of Allergy And Infectious Diseases2002–2006
Placental Protein 14 As A Lectin-Like ImmunomodulatorFogarty International Center2003–2005
Placental Protein 14 As A Unique ImmunoregulatorNational Institute Of Allergy And Infectious Diseases2001–2005
Engineering Artificial Veto CellsNational Institute Of Allergy And Infectious Diseases1999–2001
Cellular Cancer Vaccines--Gpi Protein TransferNational Cancer Institute1999–2001
Hematopoietic Pp14--An Antiinflammatory CytokineNational Institute Of Allergy And Infectious Diseases1999–2000
H19 In Bladder CancerNational Cancer Institute1999
Engineering Artificial Veto CellsNational Institute Of Allergy And Infectious Diseases1997–1998
Cellular Cancer Vaccines--Gpi Protein TransferNational Cancer Institute1997–1998
Core--Molecular BiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–1998
Hematopoietic Pp14--An Antiinflammatory CytokineNational Institute Of Allergy And Infectious Diseases1996–1998
Protein Transfer With GPI PolypeptidesNational Institute Of Diabetes And Digestive And Kidney Diseases1996
Cd8-Dependent ImmunoregulationNational Institute Of Allergy And Infectious Diseases1992–1996
Human Leukemic Differentiation--Anti-Sense RNA StudiesNational Cancer Institute1988–1992